80696-30-6

Basic information

• Product Name: D-NORVALINOL
• Synonyms: D-NORVALINOL;H-D-NVA-OL;(R)-(-)-2-AMINO-1-PENTANOL;(2R)-2-AMino-1-pentanol HCl;(R)-2-Aminopentanol;2-Amino-(2R)-1-pentanol;(R)-2-AMinopentan-1-ol
• CAS NO: 80696-30-6
• Molecular Formula: C₅H₁₃NO
• Molecular Weight: 103.16
• Product Categories: Peptide
• Mol File: 80696-30-6.mol
• Article Data: 6

Chemical Properties

• Melting Point: 44-48 °C(lit.)
• Boiling Point: 195.6 °C at 760 mmHg
• Flash Point: 204 °F
• Appearance: /
• Density: 0.915 g/cm³
• Vapor Pressure: 0.108mmHg at 25°C
• Refractive Index: 1.449
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: D-NORVALINOL(CAS DataBase Reference)
• NIST Chemistry Reference: D-NORVALINOL(80696-30-6)
• EPA Substance Registry System: D-NORVALINOL(80696-30-6)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 2
• Hazardous Substances Data: 80696-30-6(Hazardous Substances Data)

Usage

Uses

(R)-(-)-2-Amino-1-pentanol can be used as a chiral building block to prepare: A key intermediate, (R)-N-(p-toluenesulfonyl)-2-propylaziridine, which is utilized in the total synthesis of (R)-1-(benzofuran-2-yl)-2-propylaminopentane. (R)-N-benzyloxycarbonyl-aminoaldehydes as potential substrates for dihydroxyacetone phosphate (DHAP)-dependent aldolases. (R)-2-((2-Aminoquinazolin-4-yl)amino)pentan-1-ol as a potent dual toll-like receptor and modulator.

InChI:InChI=1/C5H13NO/c1-2-3-5(6)4-7/h5,7H,2-4,6H2,1H3/t5-/m1/s1

Upstream product

• 2013-12-9 D-norvaline 
• 4146-04-7 DL-2-amino-1-pentanol 

Downstream Products

• 849943-17-5 (2R)-2-{[2-amino-5-(benzylsulfanyl)-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]amino}pentan-1-ol 
• 1146355-27-2 (R)-2-{2-[4-(4-chlorophenyl)-piperidin-1-yl]-5-oxo-6,7-dihydro-5H-5λ⁴-thieno[3,2-d]pyrimidin-4-ylamino}-pentan-1-ol 
• 1449421-00-4 (R)-2-(2-aminophenylamino)pentan-1-ol 
• 116611-55-3 (R)-tert-butyl (1-hydroxypentan-2-yl)carbamate 
• 1361969-89-2 N-((R)-hept-1-yn-4-yl)-4-methyl-N-((R)-1-(pentyloxy)allyl)benzenesulfonamide 
• 1361969-88-1 N-((R)-hept-1-yn-4-yl)-4-methyl-N-((S)-1-(pentyloxy)allyl)benzenesulfonamide 
• 1361969-73-4 C₂₆H₄₁NO₃SSi 
• 1361969-72-3 C₂₆H₄₁NO₃SSi 
• 1361969-71-2 4-methyl-N-((R)-1-(pentyloxy)allyl)-N-((R)-1-(trimethylsilyl)hept-1-yn-4-yl)benzenesulfonamide 
• 1361969-69-8 4-methyl-N-((S)-1-(pentyloxy)allyl)-N-((R)-1-(trimethylsilyl)hept-1-yn-4-yl)benzenesulfonamide 
• 1361969-68-7 C₂₁H₃₃NO₃SSi 
• 1361969-52-9 (R)-4-methyl-N-(1-(trimethylsilyl)hept-1-yn-4-yl)benzenesulfonamide 
• 1361970-12-8 (2R,6R)-2-propyl-1-tosyl-6-vinylpiperidin-4-one 
• 1361970-08-2 (2R)-2-propyl-1-tosyl-6-vinylpiperidin-4-one 

Relevant articles and documents

Synthesis of imidacloprid derivatives with a chiral alkylated imidazolidine ring and evaluation of their insecticidal activity and affinity to the nicotinic acetylcholine receptor

A series of imidacloprid (IMI) derivatives with an alkylated imidazolidine ring were asymmetrically synthesized to evaluate their insecticidal activity against adult female housefly, Musca domestica, and affinity to the nicotinic acetylcholine receptor of the flies. The bulkier the alkyl group, the lower was the receptor affinity, but the derivatives methylated and ethylated at the R-5-position of the imidazolidine ring were equipotent to the unsubstituted compound. Quantitative structure-activity relationship (QSAR) analysis of the receptor affinity demonstrated that the introduction of a substituent into the imidazolidine ring was fundamentally disadvantageous, but the introduction of a substituent at the R-5-position was permissible in the case of its small size. The binding model of the synthesized derivatives with the receptor supported the QSAR analysis, indicating the existence of space for a short alkyl group around the R-5-position in the ligand-binding site. In addition, positive correlation was observed between the insecticidal activity and receptor affinity, suggesting that the receptor affinity was the primary factor in influencing the insecticidal activity even if the imidazolidine ring was modified.

COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS

The present invention relates to derivatized cyclofructan compounds, compositions comprising derivatized cyclofructan compounds, and methods of using compositions comprising derivatized cyclofructan compounds for chromatographic separations of chemical species, including enantiomers. Said compositions may comprise a solid support and/or polymers comprising derivatized cyclofructan compounds.

Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer

Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane ((-)-BPAP), which is a highly potent and selective catecholaminergic activity enhancer (CAE) substance, are described. The synthetic approach consists of the coupling reaction of benzofuran with (R)-N-tosyl-2-propylazirizine or (R)-N-methoxy-N-methylnorvaliamide, followed by appropriate modifications of the resulting coupling products. As the results, (-)-BPAP turned out to have the R configuration, which was finally confirmed by X-ray crystallographic analysis.